Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Mouton, thank you for keeping us up to date and for your legal insights. For Dew and the legal eagles, north, zip et al: Since the SC has agreed to review the case and since only a fraction of cases are granted cert, what does this mean regarding the "chances" of a reversal. In other words what percent of cases that get this far are actually reversed? The SC must feel there is merit to TEVAs argument since at least four of the justices agreed to allow the case to go forward. So can anyone 1. summarize the main remaining legal issue remaining (I looked on the RMF section but could not find an explanation of the patent in question) and or refer me to a place I can read about it and 2. Perhaps handicap the outcome, with no pulled punches as to how you think based on your knowledge and experience things are likely to go. Speculation welcome. Many thanks. I have held this stock for years and find it, well horrifying, to find myself a few months from presumed FDA approval for copax (enduring citizens petitions etc etc and now this!!) Can any share if they have modified their holdings based on recent events? Also going forward, for the unrelated biosimiliar program once they come off Orange Book will there be other land mines like this that will surface and therefore modify timelines that have been projected? Best Regards, bp